| Hans-Günter Meyer-Thompson | Hepatitiden
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial
Forns, Xavier et al.
The Lancet Infectious Diseases , Volume 0 , Issue 0 , Published: 14 August 2017, doi.org/10.1016/S1473-3099(17)30496-6
http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30496-6/fulltext